Accurate prediction of responses to transarterial chemoembolization for patients with hepatocellular carcinoma by using artificial intelligence in contrast-enhanced ultrasound
The aim of this study was to establish and validate an artificial intelligence-based radiomics strategy in order to predict personalized responses to hepatocellular carcinoma (HCC) to first transarterial chemoembolization (TACE) by analyzing contrast-enhanced ultrasound (CEUS) cines quantitatively. This was done using 130 HCC patients, showing that a deep learning-based radiomics method can effectively utilize CEUS, resulting in accurate and personalized